5UJ3

Crystal structure of the KPC-2 beta-lactamase complexed with hydrolyzed cefotaxime

5UJ3 の概要

• エントリーDOI: 10.2210/pdb5uj3/pdb
• 関連するPDBエントリー: 5UJ4 5UL8
• 分子名称: Carbapenem-hydrolyzing beta-lactamase KPC, (2R)-2-[(R)-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}(carboxy)methyl]-5-methylidene-5,6-dihydro -2H-1,3-thiazine-4-carboxylic acid, GLYCEROL, ... (4 entities in total)
• 機能のキーワード: carbapenemase, cefotaxime, beta-lactamase, complex, hydrolase-antibiotic complex, hydrolase/antibiotic
• 由来する生物種: Klebsiella pneumoniae
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 31725.58

構造登録者

Pemberton, O.A.,Chen, Y. (登録日: 2017-01-16, 公開日: 2017-04-26, 最終更新日: 2024-10-16)

主引用文献

Pemberton, O.A.,Zhang, X.,Chen, Y.
Molecular Basis of Substrate Recognition and Product Release by the Klebsiella pneumoniae Carbapenemase (KPC-2).
J. Med. Chem., 60:3525-3530, 2017

PubMed Abstract: Carbapenem-resistant Enterobacteriaceae are resistant to most β-lactam antibiotics due to the production of the Klebsiella pneumoniae carbapenemase (KPC-2) class A β-lactamase. Here, we present the first product complex crystal structures of KPC-2 with β-lactam antibiotics containing hydrolyzed cefotaxime and faropenem. They provide experimental insights into substrate recognition by KPC-2 and its unique cephalosporinase/carbapenemase activity. These structures also represent the first product complexes for a wild-type serine β-lactamase, elucidating the product release mechanism of these enzymes in general.

PubMed: 28388065
DOI: 10.1021/acs.jmedchem.7b00158

実験手法

X-RAY DIFFRACTION (1.45 Å)